MENU
+Compare
AGEN
Stock ticker: NASDAQ
AS OF
Jul 18 closing price
Price
$6.15
Change
-$0.57 (-8.48%)
Capitalization
168.61M

AGEN Agenus Forecast, Technical & Fundamental Analysis

Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body’s immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc... Show more

Industry: #Biotechnology
AGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for AGEN with price predictions
Jul 18, 2025

AGEN sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for AGEN moved above the 200-day moving average on June 23, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 02, 2025. You may want to consider a long position or call options on AGEN as a result. In of 77 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for AGEN just turned positive on July 10, 2025. Looking at past instances where AGEN's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AGEN advanced for three days, in of 246 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 104 cases where AGEN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for AGEN moved out of overbought territory on July 14, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 53 cases where AGEN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AGEN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

AGEN broke above its upper Bollinger Band on July 11, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AGEN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (18.109). P/E Ratio (0.208) is within average values for comparable stocks, (58.647). AGEN's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.460). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (1.330) is also within normal values, averaging (270.773).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AGEN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
AGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

AGEN is expected to report earnings to rise 199.03% to -307 cents per share on May 09

Agenus AGEN Stock Earnings Reports
Q1'24
Est.
$-3.08
Q1'25
Missed
by $0.77
Q4'24
Beat
by $0.84
Q4'23
Missed
by $0.07
Q3'23
Beat
by $0.04
The last earnings report on May 12 showed earnings per share of -102 cents, missing the estimate of -25 cents. With 1.08M shares outstanding, the current market capitalization sits at 168.61M.
A.I. Advisor
published General Information

General Information

a developer of technologies to treat cancers and infectious diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
3 Forbes Road
Phone
+1 781 674-4400
Employees
389
Web
https://www.agenusbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GLAPY71.00N/A
N/A
Glanbia Plc
TCKRF33.50N/A
N/A
Teck Resources Ltd.
SRTSF13.94N/A
N/A
Sarantis SA
IRCDF1.37N/A
N/A
Intercede Group PLC
MAKAF0.06-0.01
-12.31%
Hardcore Discoveries Ltd

AGEN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AGEN has been closely correlated with NCNA. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if AGEN jumps, then NCNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGEN
1D Price
Change %
AGEN100%
-8.48%
NCNA - AGEN
92%
Closely correlated
+1.92%
WINT - AGEN
91%
Closely correlated
+13.33%
NBY - AGEN
90%
Closely correlated
+2.00%
TAOX - AGEN
90%
Closely correlated
+7.55%
ALLR - AGEN
88%
Closely correlated
-0.34%
More

Groups containing AGEN

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGEN
1D Price
Change %
AGEN100%
-8.48%
AGEN
(19 stocks)
17%
Poorly correlated
+1.96%